APPLICATION
BLA761460
TYPE
BLA
ORIGINAL APPROVAL
2026-05-27
LATEST ACTION
2026-05-27
ROUTE
INTRAVENOUS, SINGLE-DOSE
DOSAGE FORM
VIAL
MARKETING STATUS
Prescription
Products
DECNUPAZPrescription
PIVEKIMAB SUNIRINE-PVZY 2MG · VIAL · SINGLE-DOSE
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.